We are live on ! Find out more
GRTX

Galera Therapeutics, Inc. Common Stock
GRTX

Delisted

GRTX was delisted on the 3rd of June, 2024.

Back to rankings

32 hedge funds and large institutions have $224M invested in Galera Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 32 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
+32
Holders Change %
–
% of All Funds
0.63%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
32
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
+$53.2M
2
NHAS
Novo Holdings A/S
Denmark
+$41.6M
3
SI
Sofinnova Investments
California
+$37.6M
4
Blackstone Inc
Blackstone Inc
New York
+$20.5M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$15.9M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
26
Citigroup
New York
$13K +$11.8K +967 New
PCM
27
Prelude Capital Management
New York
$7K +$6.8K +558 New
Deutsche Bank
28
Deutsche Bank
Germany
$7K +$6.87K +563 New
Bank of Montreal
29
Bank of Montreal
Ontario, Canada
$3K +$2.57K +211 New
Wells Fargo
30
Wells Fargo
California
$2K +$1.67K +137 New
AIP
31
Ameritas Investment Partners
Nebraska
$2K +$1.77K +145 New
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$1K +$1.23K +101 New
1
2

GRTX Hedge Fund Activity: Q4 2019 in Review

32 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Galera Therapeutics, Inc. Common Stock (GRTX) for Q4 2019, worth a combined $224M.

Buyers outnumbered sellers: 32 funds opened new GRTX positions and 0 closed out — a net gain of 32 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was NEA Management Company, opening a new position worth an estimated $53.2M.

  • 32 institutional investors held Galera Therapeutics, Inc. Common Stock (GRTX) as of Q4 2019, up from 0 in Q3 2019.
  • Funds reported $224M of Galera Therapeutics, Inc. Common Stock stock for Q4 2019.
  • 32 funds opened new Galera Therapeutics, Inc. Common Stock positions in Q4 2019 and 0 closed out, a net change of +32 holders.
  • The largest Galera Therapeutics, Inc. Common Stock buyer in Q4 2019 was NEA Management Company, an estimated $53.2M added.

Based on aggregated 13F filings for Q4 2019.